> I am still not convinced that containerizing everything brings any benefits except the collocation of services. Is there even a benefit? We as croit collocate all our services from Ceph itself MON,MGR,MDS,OSD,... as well as ISCSI, SMB, NFS,... on the same host. No problem with that, not a single one. -- Martin Verges Managing director Mobile: +49 174 9335695 E-Mail: martin.verges@xxxxxxxx Chat: https://t.me/MartinVerges croit GmbH, Freseniusstr. 31h, 81247 Munich CEO: Martin Verges - VAT-ID: DE310638492 Com. register: Amtsgericht Munich HRB 231263 Web: https://croit.io YouTube: https://goo.gl/PGE1Bx Am Mi., 17. März 2021 um 18:39 Uhr schrieb Teoman Onay <tonay@xxxxxxxxxx>: > A containerized environment just makes troubleshooting more difficult, > getting access and retrieving details on Ceph processes isn't as > straightforward as with a non containerized infrastructure. I am still not > convinced that containerizing everything brings any benefits except the > collocation of services. > > On Wed, Mar 17, 2021 at 6:27 PM Matthew H <matthew.heler@xxxxxxxxxxx> > wrote: > > > There should not be any performance difference between an > un-containerized > > version and a containerized one. > > > > The shift to containers makes sense, as this is the general direction > that > > the industry as a whole is taking. I would suggest giving cephadm a try, > > it's relatively straight forward and significantly faster for deployments > > then ceph-ansible is. > > > > ________________________________ > > From: Matthew Vernon <mv3@xxxxxxxxxxxx> > > Sent: Wednesday, March 17, 2021 12:50 PM > > To: ceph-users <ceph-users@xxxxxxx> > > Subject: ceph-ansible in Pacific and beyond? > > > > Hi, > > > > I caught up with Sage's talk on what to expect in Pacific ( > > https://www.youtube.com/watch?v=PVtn53MbxTc ) and there was no mention > > of ceph-ansible at all. > > > > Is it going to continue to be supported? We use it (and uncontainerised > > packages) for all our clusters, so I'd be a bit alarmed if it was going > > to go away... > > > > Regards, > > > > Matthew > > > > > > -- > > The Wellcome Sanger Institute is operated by Genome Research > > Limited, a charity registered in England with number 1021457 and a > > company registered in England with number 2742969, whose registered > > office is 215 Euston Road, London, NW1 2BE. > > _______________________________________________ > > ceph-users mailing list -- ceph-users@xxxxxxx > > To unsubscribe send an email to ceph-users-leave@xxxxxxx > > _______________________________________________ > > ceph-users mailing list -- ceph-users@xxxxxxx > > To unsubscribe send an email to ceph-users-leave@xxxxxxx > > > > > _______________________________________________ > ceph-users mailing list -- ceph-users@xxxxxxx > To unsubscribe send an email to ceph-users-leave@xxxxxxx > _______________________________________________ ceph-users mailing list -- ceph-users@xxxxxxx To unsubscribe send an email to ceph-users-leave@xxxxxxx
 |